Hologic hits 52-week high on mammography study | Wall Street Beat

January 10, 2013 by MassDevice staff

Shares of Hologic hit a 52-week high yesterday on a study showing the benefits of mammography using its Selenia 3D device.

MassDevice.com Wall Street Beat

Hologic (NSDQ:HOLX) shares hit a 52-week high yesterday on news that mammography using 3D technology significantly improved diagnostic accuracy.

HOLX shares reached their highest level since May 2011 yesterday, peaking at $23.22 apiece before closing at $22.36, up 7.0% on the day. Shares were trading at $22.39 as of about 12:50 p.m. today.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp